GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 29/03/2010
PIL Imigran 10mg and 20mg Nasal Spray

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/03/2010 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 18/11/2008 and displayed until 29/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 08/06/2006 and displayed until 18/11/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 01/11/2005 and displayed until 08/06/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/07/2004 and displayed until 01/11/2005
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
  • Change to Further Information section
  • Correction of spelling/typing errors
Updated on 02/09/2003 and displayed until 26/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 09/05/2002 and displayed until 02/09/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 13/03/2001 and displayed until 09/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 23/11/2000 and displayed until 13/03/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   sumatriptan